Your browser doesn't support javascript.
loading
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.
Jemec, G B E; Okun, M M; Forman, S B; Gulliver, W P F; Prens, E P; Mrowietz, U; Armstrong, A W; Geng, Z; Gu, Y; Williams, D A; Teixeira, H D; Kimball, A B.
Afiliação
  • Jemec GBE; Department of Dermatology Zealand University Hospital, Health Sciences Faculty University of Copenhagen, Roskilde, Denmark.
  • Okun MM; Fort HealthCare, Fort Atkinson, WI, U.S.A.
  • Forman SB; Forward Clinical Trials, Tampa, FL, U.S.A.
  • Gulliver WPF; Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada.
  • Prens EP; Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Mrowietz U; CHU de Reims, Hôpital Robert Debré, Service de Dermatologie, Reims Cedex, France.
  • Armstrong AW; Department of Dermatology, Venereology, and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany.
  • Geng Z; Keck School of Medicine, University of Southern California, Los Angeles, CA, U.S.A.
  • Gu Y; AbbVie Inc., North Chicago, IL, U.S.A.
  • Williams DA; AbbVie Inc., North Chicago, IL, U.S.A.
  • Teixeira HD; AbbVie Inc., North Chicago, IL, U.S.A.
  • Kimball AB; AbbVie Inc., North Chicago, IL, U.S.A.
Br J Dermatol ; 181(5): 967-975, 2019 11.
Article em En | MEDLINE | ID: mdl-30916379
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_nao_transmissiveis Assunto principal: Hidradenite Supurativa / Quimioterapia de Manutenção / Adalimumab / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_doencas_nao_transmissiveis Assunto principal: Hidradenite Supurativa / Quimioterapia de Manutenção / Adalimumab / Inibidores do Fator de Necrose Tumoral Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca